Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
06/2012
06/20/2012EP2464724A2 Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products
06/20/2012EP2464357A2 Vitamin d3 and analogs thereof for treating alopecia
06/20/2012EP2464356A1 Sigma ligands for the prevention or treatment of pain induced by chemotherapy
06/20/2012EP2464334A1 Compositions and methods for treating fungal infection of the nail
06/20/2012EP2464331A1 Stabilised particles comprising 5-methyl-(6s)-tetrahydrofolate
06/20/2012EP2464236A1 Anti-infective antimicrobial-containing biomaterials
06/20/2012EP2464229A1 Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in patients with demyelinating and other nervous system conditions
06/20/2012EP2146735B1 Compositions comprising sparc polypeptides
06/20/2012EP1902718B1 Active foam
06/20/2012EP1787647B1 Remedy for glomerular diseases
06/20/2012EP1467705B1 Therapeutic agent delivery tampon
06/20/2012EP1311267B1 A retroviral immunotherapy
06/20/2012CN1906214B Anti-IGFR1 antibody therapeutic combinations
06/20/2012CN102505006A Modulation of stem and progenitor cell differentiation, assays, and uses thereof
06/20/2012CN102504024A Antibodies that bind human interleukin-18 and methods of making and using
06/20/2012CN102504014A Peptidomimetic protease inhibitors
06/20/2012CN101939001B Combination comprising paclitaxel for treating ovarian cancer
06/20/2012CN101919799B Novel sustained-release transdermal medicament delivery system
06/20/2012CN101829329B Tooth antiallergic composition
06/20/2012CN101612124B Lipoid plasmid and preparation method of formulation thereof
06/20/2012CN101282743B Bacteriocin and novel bacterium mycopremna
06/19/2012US8203029 Silver-containing compositions, devices and methods for making
06/19/2012US8202869 Method of treating an anxiety disorder
06/19/2012US8202860 Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)
06/19/2012US8202850 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
06/19/2012US8202834 Fat regulation
06/19/2012US8202724 Methods of controlling proliferation and differentiation of stem and progenitor cells
06/19/2012US8202547 Citrate-based dialysate chemical formulations
06/19/2012US8202523 Glycosylated polypeptides produced in yeast mutants and methods of use thereof
06/19/2012US8202512 Metabolic uncoupling therapy
06/19/2012CA2529377C Compositions for improved oxidative status in companion animals
06/19/2012CA2512563C Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes
06/19/2012CA2471043C Stable surfactant compositions for suspending components
06/19/2012CA2469939C Method of inducing ovulation using a non-polypeptide camp level modulator
06/19/2012CA2422538C Notch receptor agonists and uses
06/19/2012CA2390898C Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues
06/19/2012CA2319872C Pharmaceutical composition for the treatment of hepatocellular carcinoma
06/14/2012WO2012078757A2 Combination breast cancer therapy with hsp90 inhibitory compounds
06/14/2012WO2012078504A1 TREATMENT OF CHRONIC INFLAMMATION WITH A 1,2,4-TRIAZOLO [1,5a] PYRIDINE DERIVATIVE
06/14/2012WO2012077775A1 Composition for treatment of cancer pain and use thereof
06/14/2012WO2012077774A1 Device for prophylaxis and treatment of systemic lupus erythematosus
06/14/2012WO2012077651A1 Noradrenergic and specific serotonergic antidepressant-containing transdermal patch
06/14/2012WO2012077127A1 A protein free surfactant composition for pulmonary diseases and a process for preparing the same
06/14/2012WO2012076718A1 Anti-microbial composition
06/14/2012WO2012076717A1 Pharmaceutical composition comprising trans-cinnamaldehyde and its use in the treatment of infections
06/14/2012WO2012076685A1 Arylsulfonamide derivatives for the prevention or treatment of specific ophthalmologic disorders
06/14/2012WO2012076667A1 Compounds for treatment of heart failure
06/14/2012WO2012076663A1 Antitumor combinations containing antibodies recognizing specifically cd38 and bortezomib
06/14/2012WO2012076516A1 Pharmaceutical composition comprising dutasteride
06/14/2012WO2012076323A1 Oligosaccharide composition for treating acute respiratory tract infections
06/14/2012WO2012076322A1 Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
06/14/2012WO2012076321A1 Oligosaccharide composition for treating skin diseases
06/14/2012WO2012076194A1 Combination preparations comprising a cytokine antagonist and corticosteroid
06/14/2012WO2012076193A1 Combination preparations comprising exosomes and corticosteroid
06/14/2012WO2012075679A1 Methods of metabolic targeting cancer cells using che mo- and immunotherapy for treating cancer
06/14/2012US20120149762 Gene and Protein Relating to Hepatocellular Carcinoma and Methods of Use Thereof
06/14/2012US20120149730 Methods and compositions using racemic, (r)-, and (s)-fexofenadine in combination with leukotriene inhibitors
06/14/2012US20120149666 Compositions and methods of treatment for inflammatory diseases
06/14/2012US20120149651 Caveolin peptides and their use as therapeutics
06/14/2012US20120149062 High Purity Lipopeptides
06/14/2012US20120148684 Methods useful in the treatment of bone resorption diseases
06/14/2012US20120148671 Gastric retained gabapentin dosage form
06/14/2012US20120148540 Proliferated cell lines and uses thereof
06/14/2012CA2820394A1 Pharmaceutical composition comprising trans-cinnamaldehyde and its use in the treatment of infections
06/14/2012CA2820382A1 Antitumor combinations containing antibodies recognizing specifically cd38 and bortezomib
06/14/2012CA2820124A1 Arylsulfonamide derivatives for the prevention or treatment of specific ophthalmologic disorders
06/14/2012CA2818936A1 Treatment of chronic inflammation with a 1,2,4-triazolo [1,5a] pyridine derivative
06/14/2012CA2818012A1 Oligosaccharide composition for treating acute respiratory tract infections
06/14/2012CA2818011A1 Oligosaccharide composition for treating skin diseases
06/14/2012CA2817122A1 Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
06/13/2012EP2461810A1 Methods of using c-met modulators
06/13/2012EP2399927A9 Novel compound, phosphorylation inhibitor, insulin resistance improving agent, agent to prevent or to treat diabetes, and screening method
06/13/2012EP2079485B1 Phenylpropionamide compounds and the use thereof
06/13/2012EP1636585B2 Diaryl ureas with kinase inhibiting activity
06/13/2012EP1495053B1 Angiopoietin-2 and angiopoietin-1 specific binding agents
06/13/2012EP1459070B1 Methods for diagnosis and treatment of epithelial-derived cancers, such as colorectal cancers and kidney cancers
06/13/2012EP1447095B1 Preventives and/or remedies for post-transplant arteriosclerosis as rejection of organ transplant
06/13/2012EP1414471B1 Therapeutic agents comprising pro-apoptotic proteins
06/13/2012EP1363705B1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
06/13/2012EP1235594B1 Inhibition of secretion from non-neuronal cells
06/13/2012EP1104296B1 Bioimplant formulation
06/13/2012CN1849112B Therapeutic liposomes
06/13/2012CN1390126B Use of selective estrogen receptor modulator in preparing medicine for treating obesity or reducing risk of development of obesity
06/13/2012CN102497881A Combination therapy for the treatment of diabetes
06/13/2012CN102497864A Sigma ligands for the prevention or treatment of pain induced by chemotherapy
06/13/2012CN102497862A Combination therapies with ck2 modulators
06/13/2012CN102497861A Compositions comprising a cholinesterase inhibitor for treating cognitive disorders
06/13/2012CN102488908A Flushing fluid for electrocision and application of same
06/13/2012CN101641117B Pharmaceutical composition
06/13/2012CN101439039B Fortifier
06/13/2012CN101193682B Pharmaceutical composition comprising an antiviral agent, an antitumoral agent or an antiparasitic agent, and an active agent selected among carveol, thymol, eugenol, borneol and carvacrol
06/13/2012CN101168060B Stable medicinal composition containing biguanide and sulfonylurea and preparation method thereof
06/12/2012US8198483 Phenethanolamine derivatives for treatment of respiratory diseases
06/12/2012US8198329 Memory consolidation promoting agent and method of use
06/12/2012US8198306 Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a proteasome inhibitor
06/12/2012US8198294 Treatment of dyskinesia
06/12/2012US8198286 Sodium channel blockers
06/12/2012US8198262 Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
06/12/2012US8198234 Methods of suppressing microglial activation
06/12/2012US8198231 Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains
1 ... 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 ... 1151